Neutralizing molecules to viral antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9169318
APP PUB NO 20120093834A1
SERIAL NO

13185386

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns methods and means for identifying, producing, and engineering neutralizing molecules against influenza A viruses, and to the neutralizing molecules produced. In particular, the invention concerns neutralizing molecules against various influenza A virus subtypes, including neutralizing antibodies against H5 and/or H3 and/or H1, such as, for example all of H1, H3, and H5 subtypes, and methods and means for making such molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REVOPSIS THERAPEUTICS INC4109 CHANDLERWOOD RD SPRINGFIELD IL 62711

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhatt, Ramesh Belmont, US 38 353
Horowitz, Lawrence Atherton, US 31 403
Kashyap, Arun Newark, US 9 71

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 27, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00